OUP Management Company’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

OUP Management Company’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$615K	Hold	41,028	–	–	1.38%	8
2023 Q2	$852K	Hold	41,028	–	–	1.45%	9
2023 Q1	$362K	Hold	41,028	–	–	0.72%	12
2022 Q4	$439K	Hold	41,028	–	–	0.72%	12
2022 Q3	$587K	Hold	41,028	–	–	0.91%	13
2022 Q2	$1.46M	Hold	41,028	–	–	2%	10
2022 Q1	$4.11M	Hold	41,028	–	–	3.13%	8
2021 Q4	$8.49M	Buy	+41,028	New	+$9.52M	3.83%	7

Other funds holding EFTR

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOA

Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIMG

Sonora Investment Management Group Tucson, Arizona $1.41B AUM 20.58% 1-Year Est. Return

OUP Management Company's EFTR Position: Q3 2023 in Review

OUP Management Company held its eFFECTOR Therapeutics, Inc. Common Stock (EFTR) position steady in Q3 2023 at 41,028 shares worth $615K. The position accounts for 1.38% of the portfolio, ranked #8.

OUP Management Company first reported a position in EFTR in Q4 2021 and has held it in 8 quarters since. The position peaked at $8.49M in Q4 2021. 29 funds tracked by Wall St. Rank hold EFTR as of Q3 2023.

OUP Management Company held 41,028 shares of eFFECTOR Therapeutics, Inc. Common Stock worth $615K as of Q3 2023.
OUP Management Company left its eFFECTOR Therapeutics, Inc. Common Stock share count unchanged in Q3 2023.
eFFECTOR Therapeutics, Inc. Common Stock made up 1.38% of OUP Management Company's portfolio in Q3 2023, its #8 holding.
OUP Management Company first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q4 2021 and has held it in 8 quarters since.
OUP Management Company's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $8.49M in Q4 2021.
29 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.